Needham & Company
View Older Stories
-
Liquidia Corporation to Present at the 24th Annual Needham Virtual Healthcare Conference
-
Liquidia Technologies (LQDA) Raises $67.5M from Share Sales, $32.5M Advance from HealthCare Royalty Under Current Financing Agreement
-
Liquidia Corporation Announces Raise of $67.5 Million from New Common Stock Financings and $32.5 Million Advance from HealthCare Royalty Under Current Financing Agreement
-
Liquidia Corporation to Present at 23rd Annual Needham Virtual Healthcare Conference
-
Liquidia Corporation to Present at 22nd Annual Needham Virtual Healthcare Conference
-
Liquidia Corporation to Present at 22nd Annual Needham Virtual Healthcare Conference
-
Liquidia Technologies (LQDA) PT Raised to $16 at Needham & Company
-
Liquidia Technologies (LQDA) Defended by Needham & Company Despite Tyvaso DPI Approval, Cites "Significant Potential of Yutrepia"
-
Liquidia Announces Closing of Public Offering of Common Stock and Full Exercise of Over-Allotment Option
-
Liquidia Announces Closing of Public Offering of Common Stock and Full Exercise of Over-Allotment Option
-
Liquidia Technologies (LQDA) Prices 9.8M Share Offering at $5.10/sh
-
Liquidia Announces Pricing of Public Offering of Common Stock
-
Liquidia Announces Pricing of Public Offering of Common Stock
-
Liquidia Technologies (LQDA) Announces Proposed Stock Offering, Size not Disclosed
-
Liquidia Announces Proposed Offering of Common Stock
-
Liquidia Announces Proposed Offering of Common Stock
-
Needham & Company Reiterates Buy Rating, $12 PT on Liquidia Technologies (LQDA) on Yutrepia Potential
-
Needham & Company Reiterates Liquidia Technologies (LQDA) at Buy, Continues to Expect Full Approval of Yutrepia
-
Liquidia Technologies (LQDA) CEO Change and Litigation Developments Improve Outlook - Needham
-
Liquidia Technologies (LQDA) PT Raised to $12 at Needham & Company
-
Liquidia Technologies (LQDA) PT Raised to $8 at Needham & Company
-
Liquidia Corporation To Present At The 20th Annual Needham Virtual Healthcare Conference
-
Liquidia Corporation To Present At The 20th Annual Needham Virtual Healthcare Conference
-
Liquidia Announces Closing of Public Offering of Common Stock
-
Liquidia Announces Closing of Public Offering of Common Stock
-
Liquidia Technologies (LQDA) Prices 9.375M Share Common Offering at $8/Sh
-
Liquidia Announces Pricing of Public Offering of Common Stock
-
Liquidia Announces Pricing of Public Offering of Common Stock
-
Liquidia Technologies (LQDA) to Offer Common Stock
-
Liquidia Announces Proposed Offering of Common Stock
-
Liquidia Announces Proposed Offering of Common Stock
-
Liquidia to Present at the 19th Annual Needham Healthcare Conference
-
Liquidia to Present at the 19th Annual Needham Healthcare Conference
-
Liquidia Technologies to Present at Needham Healthcare Conference
-
Liquidia Technologies to Present at Needham Healthcare Conference
-
Liquidia Technologies Announces Closing of Offering of Common Stock
-
Liquidia Technologies Announces Closing of Offering of Common Stock
-
Liquidia Technologies (LQDA) Prices 3M Share Common Stock Offering at $11.50/Share
-
Liquidia Technologies Announces Pricing of Offering of Common Stock
-
Liquidia Technologies Announces Pricing of Offering of Common Stock
-
Liquidia Technologies (LQDA) Announces Proposed Offering of Common Stock
-
Liquidia Technologies Announces Proposed Offering of Common Stock
-
Liquidia Technologies Announces Proposed Offering of Common Stock
-
Liquidia Technologies (LQDA) PT Raised to $32 at Needham & Company
-
Needham & Company Starts Liquidia Technologies (LQDA) at Buy
-
Liquidia Technologies Announces Closing of Initial Public Offering
-
Liquidia (LQDA) IPO Opens 13% Higher
-
Liquidia Technologies, Inc. (LQDA) Prices 4.55M Share IPO at $11/Sh
-
Liquidia Technologies Announces Pricing of Initial Public Offering

